FDA advisers support Novavax's Covid-19 vaccine for authorization
Headline from KYMA Yuma, on the newest of 3 developments
Vaccine advisers to the US Food and Drug Administration decided Tuesday that authorizing Novavax's Covid-19 vaccine -- which uses different technology from the three vaccines currently in use in the US -- for emergency use in adults would be beneficial.
KYMA Yuma's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
3 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
New COVID-19 vaccine option Novavax hopes to win over FDA, Americans
Headline from Fox5 Atlanta ·
FDA advisers to weigh risks and benefits of Novavax's COVID-19 vaccine
Headline from ABC 12 Flint ·
Newest
FDA advisers support Novavax's Covid-19 vaccine for authorization
Americans may soon get a new COVID-19 vaccine option — shots made with a more tried-and-true technology than today’s versions. The big question: Why should they care?
The Novavax vaccine appears to be safe and about 90% effective at preventing mild, moderate and severe COVID-19, Food and Drug Administration scientists say in an analysis of the company's data.
After more than a year with two types of Covid-19 vaccines in use in the United States, another will be up for consideration by the US Food and Drug Administration next week.
The Food and Drug Administration’s independent experts will review the safety and effectiveness of Novavax’s Covid vaccine Tuesday. If they endorse the vaccine, the FDA will almost certainly authorize the shot for adults in the U.S.
A more traditional kind of COVID-19 vaccine is a step closer to becoming the fourth option for U.S. adults. Advisers to the Food and Drug Administration voted Tuesday to recommend
A more traditional kind of COVID-19 vaccine has moved a step closer to the U.S. market. Advisers to the Food and Drug Administration voted Tuesday to back shots made by
A Food and Drug Administration (FDA) advisory committee is meeting on Tuesday to discuss a request for emergency use authorization (EUA) for Novavax COVID vaccines.
FDA's vaccine chief said another choice in the U.S. may entice at least some vaccine holdouts - whatever their reason - to consider rolling up their sleeves.
The Food and Drug Administration's panel of vaccine experts has voted overwhelmingly to authorize Novavax's two-dose COVID-19 vaccine, paving the way for a new option that officials hope will attract unvaccinated people.
The Food and Drug Administration’s advisory committee voted unanimously to recommend Novavax’s Covid-19 vaccine for use in the U.S. The FDA usually follows the committee’s recommendations, though it is not obligated to do so. The agency could clear Novavax’s vaccine for distribution in the U.S.
Vaccine advisers to the US Food and Drug Administration decided Tuesday that authorizing Novavax's Covid-19 vaccine -- which uses different technology from the three vaccines currently in use in the US -- for emergency use in adults would be beneficial.
The Food and Drug Administration is set to discuss authorization of the Novavax COVID-19 vaccine, a shot that earned massive government investment in the early throes of the pandemic but hit several manufacturing barriers to regulatory approval.
American adults who haven’t yet gotten vaccinated against covid-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot. Next, the FDA must decide whether to authorize the vaccine made by latecomer Novavax, a protein vaccine t…
Advisers signaled interest in making available a vaccine made with a technology different from the messenger RNA shots that have dominated the U.S. immunization arsenal against the disease.
A panel of experts convened by the US drug regulator was meeting Tuesday to consider authorizing the Novavax Covid-19 shot, a late runner in the fight against the virus that could nonetheless play a…
Showing the first 25 of 35 headlines. ·
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
FDA advisers support Novavax's Covid-19 vaccine for authorization | Since Then
